Caperna's Merger

Caperna raised a round of funding on September 14, 2017. Investors include Moderna Therapeutics.

Caperna, the fourth venture company formed by Moderna, is focused exclusively on the advancement of personalized cancer vaccines. Caperna is leveraging Moderna's messenger RNA Therapeutics platform, a…

Articles about Caperna's Merger: